GC40213
Regorafenib-13C-d3
Also known as 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-(trideuterio(113C)methyl)pyridine-2-carboxamide
Regorafenib-13C-d3 is intended for use as an internal standard for the quantification of regorafenib by GC- or LC-MS
ChemicalCAS2126178-55-8MW486.8FormulaC20[13C]H12D3ClF4N4O3
- CAS number
- 2126178-55-8
- Molecular weight
- 486.8
- Formula
- C20[13C]H12D3ClF4N4O3
- Solubility
- DMF： 30 mg/ml,DMSO： 30 mg/ml,Ethanol： 14 mg/ml
- InChIKey
- FNHKPVJBJVTLMP-KQORAOOSSA-N
- Catalogue number
- GC40213
- Brand
- GLPBIO
Computed properties PubChem CID 76974621 · XLogP 4.2 · TPSA 92.4 Ų · H-bond donors 3
- XLogP
- 4.2
- TPSA
- 92.4 Ų
- H-bond donors
- 3
- H-bond acceptors
- 8
- Rotatable bonds
- 5
- Heavy atoms
- 33
SMILES [2H][13C]([2H])([2H])NC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F
Computed descriptors from PubChem (CID 76974621), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il